Intra-arterial 5-FU for Colorectal Liver Metastases
Author Information
Author(s): JD Howell, CS McArdle, DJ Kerr, J Buckles, JA Ledermann, I Taylor, HJ Gallagher, J Budden
Hypothesis
Intra-arterial treatment is associated with higher response rates and possibly prolonged survival compared with systemic therapy.
Conclusion
The study found a 46% overall response rate with a median survival of 19 months for patients treated with intra-arterial 5-FU.
Supporting Evidence
- Overall response rate was 46% with 8% complete response.
- Median follow-up was 17 months.
- Median survival was estimated at 19 months.
- Eight patients experienced grade 3 or 4 toxicity.
Takeaway
Doctors gave a special medicine directly to the liver to help people with cancer, and many of them got better for a while.
Methodology
Patients received intra-arterial 5-FU and folinic acid, with treatment cycles repeated every two weeks, and responses assessed after six treatments.
Potential Biases
Potential bias due to lack of randomization and the observational nature of the study.
Limitations
The study had a small sample size and was not randomized against a control group.
Participant Demographics
42 patients (17 female, 25 male) with a median age of 60 years.
Want to read the original?
Access the complete publication on the publisher's website